Fumie Griego joins International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) as new Assistant Director General

Published on: 02 May 2017

IFPMA Director-General Thomas Cueni announced today that former PhRMA and Merck KGaA executive, Dr Fumie Griego, has joined the organization as Assistant Director General (ADG) for strategic planning, policy, and research.

“I am delighted to count on the support of Fumie Griego, a highly competent professional, whom I have chosen for her strong pharma expertise and background in global affairs, including intellectual property protection, pricing, costs and value issues, and health diplomacy. She will be a strong asset to help IFPMA bring thought leadership in addressing global health challenges.”

Prior to joining IFPMA, Fumie was Head of Global Oncology Policy and Strategy, Global Government Affairs & Policy at Merck KGaA and Vice President for International Health Policy at Pharmaceutical Research and Manufacturers of America (PhRMA). Prior to that, Fumie was as a senior economist in the White House’s Office of Management and Budget, where she provided U.S. senior officials in both the Bush and Obama Administrations with advice on a range of health policy issues. Fumie holds a PHD in Health Policy from Harvard University and Bachelor and Master of Science degrees in Earth Systems (concentration in environmental economics and policy) from Stanford University.

Joining the leadership team with Brendan Shaw, Assistant Director General, Fumie will be instrumental in strengthening IFPMA’s work on the industry’s value proposition and provide leadership on strategic planning, policy, and research.  

About IFPMA

IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees discover, develop and deliver medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.

For further information, please contact:

Sadia Kaenzig | Communications Manager | s.kaenzig@ifpma.org | +41795134442

Morgane De Pol | Manager, Communications and Public Affairs | m.depol@ifpma.org +41 22 338 32 00


ABOUT IFPMA

IFPMA represents research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry's 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.

MEDIA ENQUIRIES

Morgane De Pol
Manager, Communications and Public Affairs
+41 22 338 32 00

Sadia Kaenzig
Manager, Communications
+41 22 338 32 00

Tags